Patients with severe asthma report fatigue, sleep disturbances, physical inactivity, and reduced work productivity as some of ...

（2025年3月24日，中国上海）今日，阿斯利康宣布重度嗜酸粒细胞性哮喘（SEA）创新靶向生物制剂凡舒卓（通用名：本瑞利珠单抗注射液）在中国正式商业上市，用于成人和12岁及以上青少年重度嗜酸粒细胞性哮喘的维持治疗1。本瑞利珠单抗是精准靶向嗜酸性粒细胞 ...

Patients with severe asthma required fewer steroid bursts with tezepelumab-ekko, according to a poster presented at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization ...

In recent years, they’ve proven effective at treating severe asthma. Asthma treatments have become pretty understandable by now. You take long-term control medications to avoid asthma attacks ...

Severe asthma is a chronic respiratory condition in which your symptoms are more intense and difficult to control than mild-to-moderate cases. Treatments include corticosteroids, biologics ...

Medically reviewed by Sanja Jelic, MD Asthma is a condition that makes breathing difficult due to swelling and tightening of the airways. It is caused by a combination of genetic, environmental, and ...

Interleukin 15 expression in asthmatic airways negatively correlated with lung function, a finding that improves understanding of asthma heterogeneity.

The number of people going to emergency five or more times in the last year because of breathing issues has risen by nearly 23 per cent ...

New therapeutic "cocktails" could offer long-lasting relief for treatment-resistant asthma and other inflammatory diseases of ...

A new report ranks Dallas as one of the most challenging places to live with seasonal allergies. A North Texas doctor ...

In a phase 4 trial, dupilumab effectively reduces airway inflammation and mucus plugging, improving lung function and asthma control in patients with moderate to severe type 2 asthma.